C4 Therapeutics Q1 2026 Earnings Narrower Loss Surprises as Biotech Advances Pipeline PRIM Q1 2026 Earnings EPS Misses Estimates by 315 Amid Operational Headwinds IAG Q1 2026 Earnings EPS Surges Past Estimates Stock Reacts Negatively DoubleVerify Q1 2026 Earnings EPS Misses Estimates Stock Declines Biomerica Q1 2026 Earnings Net Loss of 044 Per Share Amid Lack of Revenue Disclosure AKTS Q1 2026 Earnings ClinicalStage Biotech Posts WiderThanExpected Loss Shares Edge Higher